HealthQuill Tumours
BioNTech, a German immunotherapy company, announced a strategic pact with OncoC4, a private firm, to develop and commercialise a drug to treat solid tumours.
Drugs Medical Pharma

BioNTech, OncoC4 in pact to develop drug for solid tumours

BioNTech, a German immunotherapy company, announced a strategic pact with OncoC4, a private firm, to develop and commercialise a drug to treat solid tumours.

Read More
Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.
Drugs Medical Pharma

Pfizer to buy Seagen for $43 billion to fortify cancer portfolio

Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.

Read More
X